Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $90.49 million. The enterprise value is $92.29 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 7.21 million shares outstanding. The number of shares has increased by 102.28% in one year.
| Current Share Class | 7.21M |
| Shares Outstanding | 7.21M |
| Shares Change (YoY) | +102.28% |
| Shares Change (QoQ) | +10.19% |
| Owned by Insiders (%) | 2.63% |
| Owned by Institutions (%) | 29.13% |
| Float | 4.15M |
Valuation Ratios
The trailing PE ratio is 6.38 and the forward PE ratio is 13.79.
| PE Ratio | 6.38 |
| Forward PE | 13.79 |
| PS Ratio | 0.95 |
| Forward PS | 1.76 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 3.94 |
| EV / Sales | 0.61 |
| EV / EBITDA | 2.06 |
| EV / EBIT | 2.16 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02
| Current Ratio | 1.02 |
| Quick Ratio | 0.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.31 |
| Debt / FCF | n/a |
| Interest Coverage | 10.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 30.86% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 352.48% |
| Revenue Per Employee | $993,007 |
| Profits Per Employee | $152,948 |
| Employee Count | 153 |
| Asset Turnover | 1.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | 0.05% |
Stock Price Statistics
The stock price has decreased by -5.82% in the last 52 weeks. The beta is -0.41, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | -5.82% |
| 50-Day Moving Average | 14.04 |
| 200-Day Moving Average | 10.11 |
| Relative Strength Index (RSI) | 42.48 |
| Average Volume (20 Days) | 65,027 |
Short Selling Information
The latest short interest is 176,777, so 2.45% of the outstanding shares have been sold short.
| Short Interest | 176,777 |
| Short Previous Month | 168,549 |
| Short % of Shares Out | 2.45% |
| Short % of Float | 4.26% |
| Short Ratio (days to cover) | 3.05 |
Income Statement
In the last 12 months, ATRA had revenue of $151.93 million and earned $23.40 million in profits. Earnings per share was $1.97.
| Revenue | 151.93M |
| Gross Profit | 71.05M |
| Operating Income | 42.69M |
| Pretax Income | 23.41M |
| Net Income | 23.40M |
| EBITDA | 44.85M |
| EBIT | 42.69M |
| Earnings Per Share (EPS) | $1.97 |
Full Income StatementBalance Sheet
The company has $13.71 million in cash and $16.96 million in debt, giving a net cash position of -$3.25 million or -$0.45 per share.
| Cash & Cash Equivalents | 13.71M |
| Total Debt | 16.96M |
| Net Cash | -3.25M |
| Net Cash Per Share | -$0.45 |
| Equity (Book Value) | -36.63M |
| Book Value Per Share | -5.08 |
| Working Capital | 375,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.71 million and capital expenditures -$90,000, giving a free cash flow of -$69.80 million.
| Operating Cash Flow | -69.71M |
| Capital Expenditures | -90,000 |
| Free Cash Flow | -69.80M |
| FCF Per Share | -$9.68 |
Full Cash Flow StatementMargins
Gross margin is 46.76%, with operating and profit margins of 28.10% and 15.40%.
| Gross Margin | 46.76% |
| Operating Margin | 28.10% |
| Pretax Margin | 15.41% |
| Profit Margin | 15.40% |
| EBITDA Margin | 29.52% |
| EBIT Margin | 28.10% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -102.28% |
| Shareholder Yield | -102.28% |
| Earnings Yield | 26.28% |
| FCF Yield | -78.39% |
Analyst Forecast
The average price target for ATRA is $21.00, which is 67.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 67.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 10.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -83.42 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -83.42 |
| Piotroski F-Score | 5 |
